RxDoctor Payments Data

Adan Hernandez, MD

Family Medicine · Hollywood, FLNPI 1699739565

Payments from drug & device makers

$9,654in general payments, 2019–2025

Across 558 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Novo Nordisk$987
  • AstraZeneca$927
  • Lilly USA, LLC$742
  • Amgen$696
  • Pfizer$572
  • plus $5K from 40 others

What the payments were for

  • Food & beverage$9,628100%
  • Education$250%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,654 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$36,681
Medicare patients
87
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$77,185
EliquisApixaban48$61,801
OzempicSemaglutide50$59,642
FarxigaDapagliflozin Propanediol36$54,704
Tresiba Flextouch U-200Insulin Degludec30$53,233
TradjentaLinagliptin35$50,392
JardianceEmpagliflozin29$48,804
Tresiba Flextouch U-100Insulin Degludec22$32,484
VascepaIcosapent Ethyl25$24,243
JanuviaSitagliptin Phosphate16$22,587
MounjaroTirzepatide21$21,759
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$17,986
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$15,317
ShingrixVaricella-Zoster Ge/As01b/Pf53$11,790
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$10,645

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Shingrix, Arexvy$1,119$99,612153 claims
Boehringer IngelheimTradjenta, Jardiance$163$99,19664 claims
AstraZenecaFarxiga, Breztri Aerosphere$927$70,02150 claims
PfizerEliquis$572$61,80148 claims
Novo NordiskOzempic$987$59,64250 claims
MerckJanuvia$128$22,58716 claims
Lilly USA, LLCMounjaro$742$21,75921 claims
AbbVieSynthroid$368$5,20638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →